Medicare Group Q.P.S.C Past Earnings Performance
Past criteria checks 1/6
Medicare Group Q.P.S.C's earnings have been declining at an average annual rate of -2.7%, while the Healthcare industry saw earnings growing at 11.3% annually. Revenues have been growing at an average rate of 0.7% per year. Medicare Group Q.P.S.C's return on equity is 7.8%, and it has net margins of 15%.
Key information
-2.7%
Earnings growth rate
-2.8%
EPS growth rate
| Healthcare Industry Growth | 13.4% |
| Revenue growth rate | 0.7% |
| Return on equity | 7.8% |
| Net Margin | 15.0% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Medicare Group Q.P.S.C's (DSM:MCGS) Returns On Capital Tell Us There Is Reason To Feel Uneasy
May 26
Investors In Medicare Group Q.P.S.C. (DSM:MCGS) Should Consider This, First
Apr 08Dividend Investors: Don't Be Too Quick To Buy Medicare Group Q.P.S.C. (DSM:MCGS) For Its Upcoming Dividend
Mar 18Medicare Group Q.P.S.C.'s (DSM:MCGS) Stock Going Strong But Fundamentals Look Weak: What Implications Could This Have On The Stock?
Mar 09Be Wary Of Medicare Group Q.P.S.C (DSM:MCGS) And Its Returns On Capital
Feb 16
Should You Use Medicare Group Q.P.S.C's (DSM:MCGS) Statutory Earnings To Analyse It?
Jan 28Can You Imagine How Medicare Group Q.P.S.C's (DSM:MCGS) Shareholders Feel About The 20% Share Price Increase?
Jan 05How Does Medicare Group Q.P.S.C. (DSM:MCGS) Fare As A Dividend Stock?
Dec 15Medicare Group Q.P.S.C.'s (DSM:MCGS) Has Been On A Rise But Financial Prospects Look Weak: Is The Stock Overpriced?
Nov 29Revenue & Expenses Breakdown
How Medicare Group Q.P.S.C makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 513 | 77 | 92 | 0 |
| 30 Jun 24 | 498 | 69 | 88 | 0 |
| 31 Mar 24 | 488 | 67 | 86 | 0 |
| 31 Dec 23 | 486 | 66 | 86 | 0 |
| 30 Sep 23 | 483 | 82 | 83 | 0 |
| 30 Jun 23 | 488 | 86 | 82 | 0 |
| 31 Mar 23 | 498 | 81 | 86 | 0 |
| 31 Dec 22 | 487 | 79 | 85 | 0 |
| 30 Sep 22 | 488 | 82 | 83 | 0 |
| 30 Jun 22 | 496 | 83 | 85 | 0 |
| 31 Mar 22 | 477 | 74 | 82 | 0 |
| 31 Dec 21 | 484 | 79 | 82 | 0 |
| 30 Sep 21 | 485 | 89 | 82 | 0 |
| 30 Jun 21 | 495 | 87 | 83 | 0 |
| 31 Mar 21 | 471 | 87 | 76 | 0 |
| 31 Dec 20 | 477 | 86 | 81 | 0 |
| 30 Sep 20 | 482 | 84 | 86 | 0 |
| 30 Jun 20 | 458 | 75 | 85 | 0 |
| 31 Mar 20 | 493 | 79 | 90 | 0 |
| 31 Dec 19 | 491 | 78 | 90 | 0 |
| 30 Sep 19 | 483 | 88 | 76 | 0 |
| 30 Jun 19 | 485 | 85 | 79 | 0 |
| 31 Mar 19 | 485 | 84 | 86 | 0 |
| 31 Dec 18 | 484 | 85 | 85 | 0 |
| 30 Sep 18 | 488 | 84 | 88 | 0 |
| 30 Jun 18 | 483 | 81 | 93 | 0 |
| 31 Mar 18 | 480 | 83 | 95 | 0 |
| 31 Dec 17 | 471 | 80 | 98 | 0 |
| 30 Sep 17 | 471 | 66 | 116 | 0 |
| 30 Jun 17 | 463 | 67 | 107 | 0 |
| 31 Mar 17 | 469 | 69 | 108 | 0 |
| 31 Dec 16 | 469 | 65 | 109 | 0 |
| 30 Sep 16 | 498 | 87 | 102 | 0 |
| 30 Jun 16 | 529 | 115 | 101 | 0 |
| 31 Mar 16 | 562 | 145 | 106 | 0 |
| 31 Dec 15 | 596 | 180 | 101 | 0 |
| 30 Sep 15 | 594 | 196 | 114 | 0 |
| 30 Jun 15 | 581 | 197 | 113 | 0 |
| 31 Mar 15 | 561 | 197 | 100 | 0 |
| 31 Dec 14 | 528 | 182 | 94 | 0 |
| 30 Sep 14 | 486 | 149 | 91 | 0 |
| 30 Jun 14 | 459 | 125 | 90 | 0 |
| 31 Mar 14 | 435 | 99 | 89 | 0 |
| 31 Dec 13 | 418 | 89 | 88 | 0 |
Quality Earnings: MCGS has high quality earnings.
Growing Profit Margin: MCGS's current net profit margins (15%) are lower than last year (17%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: MCGS's earnings have declined by 2.7% per year over the past 5 years.
Accelerating Growth: MCGS's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: MCGS had negative earnings growth (-6.3%) over the past year, making it difficult to compare to the Healthcare industry average (8.3%).
Return on Equity
High ROE: MCGS's Return on Equity (7.8%) is considered low.